AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT01544634 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Placebo tablets: 1 tab bd for 2 weeks, 1 tab od for 4 weeks
Study NCT01544634 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Qvar 50
Description: Qvar 50, 1 puff bd for 6 weeks
Study NCT01544634 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Qvar 100
Description: Qvar 100, 2 puffs bd for 6 weeks
Study NCT04198571 — intervention group
Intervention type: DRUG
Intervention: Zinforo (ceftaroline fosamil)
Description: IV Solution
Study NCT01913262 — intervention group
Intervention type: BEHAVIORAL
Intervention: Standard Behavioral treatment
Description: Standard behavioral treatment (e.g. problem solving therapy, cognitive behavioral treatment)
Study NCT03044977 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 90Y-DOTA-3-Tyr-Octreotide
Description: Peptide receptor radiotherapy (PRRT) using Yttrium-90 as the active radionuclide. For intravenous administration only.
Study NCT03044977 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 131I-MIBG
Description: Peptide receptor radiotherapy (PRRT) using Iodine-131 as the active radionuclide. For intravenous administration only.
Study NCT02876952 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: HIGH VOLUME (HV) Supervised exercise
Description: Supervised exercise two nonconsecutive days per week (day 1-on the treadmill, day 2-on the bike) for 16 weeks. High-intensity interval training (HIIT) protocol on the treadmill: 5-min warm-up at a moderate-intensity, before walking 2 intervals of 4 min at high-intensity interspersed with intervals of 3 min of walking at moderate-intensity. 1-4 min cool-down at moderate-intensity.~HIIT protocol on the bike: 5 to 10-min warm-up at moderate intensity. After that, 4 repetitions (1rep = 30 s high-intensity followed by 60 s moderate-intensity) and gradually increased to 16 repetitions in HV-HIIT week by week. 5-10 min cool-down at moderate-intensity
Study NCT02876952 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Mediterranean Diet Recommendations
Description: Participants will be interviewed regarding their usual eating habits. They will receive practical information about which are the Mediterranean Diet (DMed) foods according to the model proposed in the PREDIMED trial. Medical doctors or nurses will give this information.~Before starting the program of intervention, participants will assist to an informative talk in which benefits for the health of the DMed will be exposed and general information about food composition, frequencies of consumption, etc. will be explained.~Nutritional management: Diet reviews and body mass control will be performed every two weeks to assess the body composition and adherence to treatment. In the event of poor compliance strategies will be addressed for its correction.
Study NCT00564278 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Standard antidepressant therapy (SADT)
Description: Treatment with medication will follow the Texas Medication Algorithm (TMA) for Depression. Antidepressant medications may include the following: citalopram (Celexa), escitalopram (Lexapro), paroxetine (Paxil CR), sertraline (Zoloft), venlafaxine XR (Effexor XR), bupropion SR (Wellbutrin SR), duloxetine (Cymbalta), nortriptyline (Pamelor), and mirtazapine (Remeron).
Study NCT00564278 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standard antidepressant therapy (SADT)
Description: Treatment with medication will follow the Texas Medication Algorithm (TMA) for Depression. Antidepressant medications may include the following: citalopram (Celexa), escitalopram (Lexapro), paroxetine (Paxil CR), sertraline (Zoloft), venlafaxine XR (Effexor XR), bupropion SR (Wellbutrin SR), duloxetine (Cymbalta), nortriptyline (Pamelor), and mirtazapine (Remeron).
Study NCT00564278 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational antidepressant therapy (MADT)
Description: The same medication treatment for depression will be offered and supplemented with techniques from motivational interviewing.
Study NCT03365960 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Watermelon Rind
Description: watermelon rind
Study NCT03365960 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Watermelon Flesh
Description: watermelon flesh
Study NCT03365960 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Watermelon Seeds
Description: watermelon seeds
Study NCT03365960 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Control Comparator
Study NCT02399969 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Battlefield Acupuncture
Description: Patients with low back pain will be randomized to receive Battlefield Acupuncture, ASP indwelling needles in 5 auricular (ear) points plus standard of care, or patients will be randomized to receive standard of care alone.
Study NCT02298036 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: (Remote) Cognitive Behaviour Therapy
Description: Randomised controlled trial of 6-10 sessions of CBT for health anxiety delivered remotely via video calling or the telephone versus treatment as usual. Treatment as usual will be that decided by the patient with their general practitioner and other health providers they consult for unscheduled/urgent care.
Study NCT01526278 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Maxmarvil®
Description: Drug : Maxmarvil® 1tablet one time in clinical trial, PO medication
Study NCT02567097 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Self-Incentive
Description: Participants are asked to form plans to quit smoking using various descriptions specified dependent on the arm in which they are randomised.
Study NCT02567097 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-Incentive
Description: Participants are asked to form plans to quit smoking using various descriptions specified dependent on the arm in which they are randomised.
Study NCT02758197 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Description: Participants assigned to this group will be enrolled in an Mindfulness-Based Stress Reduction (MBSR) course directly following medical treatment optimization. The MBSR course consists of eight weekly 2-hour sessions and one 6 hour session midway through the course and involves psychoeducation, relaxation techniques, gentle stretching (very mild form of yoga), and different forms of meditation. Participants will learn ways to better cope with their pain and the disability and distress related to it with a goal of reducing the stress response that is our body's normal reaction to pain. All sessions will be conducted by a psychologist or social worker with a minimum of 2 years of experience in chronic pain management, formal MBSR training and 2 years of experience leading MBSR groups.
Study NCT04386161 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Scheduled exercise program
Description: 45 minutes of stretching, strengthening, and balance-coordination exercises and 20 minutes of balance training on the Balance Master® device twice a week for six weeks
Study NCT00790556 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MK8245
Description: MK8245 50 mg capsules twice daily for 13 days. On Day 14, only the morning dose of study medication will be taken. There will be a 14 day washout period. Patients will then crossover to MK8245 placebo capsules twice daily for 13 days. On Day 14, only the morning dose of study drug will be taken.
Study NCT00790556 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Comparator: Placebo
Description: MK8245 placebo capsules twice daily for 13 days. On Day 14, only the morning dose of study medication will be taken. There will be a 14 day washout period. Patients will then crossover to MK8245 50 mg capsules twice daily for 13 days. On Day 14, only the morning dose of study drug will be taken.
Study NCT03061487 — intervention group
Intervention type: PROCEDURE
Intervention: Open Surgical Treatment of Aneurysm (Aneurysmectomy)
Description: Aneurysmectomy is a surgical procedure in which a localized, dilated, weakened section of an artery (aneurysm) is removed (resected). The artery is either replaced with a synthetic graft, as seen in an aneurysm in the chest (thoracic aneurysm), abdomen (abdominal aneurysm) or leg (femoral or popliteal aneurysm).
Study NCT01679028 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: T89 Group A
Description: 150mg single dose on day 1
Study NCT01679028 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Group A
Description: 150mg single dose
Study NCT01679028 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Group B
Description: 300mg single dose
Study NCT01679028 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: T89 Group B
Description: 300mg single dose
Study NCT02876952 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mediterranean Diet Recommendations
Description: Participants will be interviewed regarding their usual eating habits. They will receive practical information about which are the Mediterranean Diet (DMed) foods according to the model proposed in the PREDIMED trial. Medical doctors or nurses will give this information.~Before starting the program of intervention, participants will assist to an informative talk in which benefits for the health of the DMed will be exposed and general information about food composition, frequencies of consumption, etc. will be explained.~Nutritional management: Diet reviews and body mass control will be performed every two weeks to assess the body composition and adherence to treatment. In the event of poor compliance strategies will be addressed for its correction.
Study NCT01679028 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Group C
Description: 225mg bid
Study NCT01679028 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: T89 Group C
Description: 225mg bid
Study NCT03000322 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cooling Vest
Description: A cool therapy device intended to provide moderate, controlled cooling (approximately 15C/59F) by absorbing heat. The material in the vest is safe, non-toxic, and eco-friendly.
Study NCT04678609 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: CKC: exercise with joints fixed on the ground OKC: exercise with joints not fixed on the ground
Study NCT02186899 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasound Guided Femoral Sciatic Obturator nerve blocks
Study NCT02186899 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: General Anesthesia femoral bolus
Study NCT02186899 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: General anesthesia femoral continuous
Study NCT05867680 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Online Mothers and Babies Course (eMB)
Description: The eMB is an online, asynchronous, self-administered intervention modeled after the efficacious and in-person Mothers and Babies Course. (4) The eight-week course includes psychoeducational modules containing YouTube videos, vignettes, interactive quizzes, homework, guided meditations, and downloadable resources that teach strategies to promote a healthy outcome for mothers and their newborns: 1) overview, 2) thoughts and my mood, 3) fighting harmful and increasing helpful thoughts, 4) activities and my mood, 5) pleasant activities help make a healthy reality, 6) contact with others and my mood, 7) planning for the future and graduation, 8) relaxation exercises.
Study NCT00707980 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vortioxetine
Description: Encapsulated vortioxetine immediate-release tablets
Study NCT00348335 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cyclosporine 0.05%
Study NCT00348335 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ocular lubricant
Study NCT02020889 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Mepolizumab
Description: Mepolizumab will be provided as a lyophilized cake in sterile vials for individual use to be reconstituted with sterile water for Injection, just prior to use.
Study NCT02020889 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be available as 0.9% sodium chloride
Study NCT03001908 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: glenohumeral mobilization-oscillation
Description: posterior glide mobilizations oscillated at 1hz, 4 x 30 seconds
Study NCT03001908 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: glenohumeral mobilization-oscillation
Description: posterior glide mobilizations oscillated at 1hz, 4 x 30 seconds
Study NCT03001908 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: glenohumeral mobilization-sustained
Description: posterior glide mobilization, sustained 4 x 30 seconds
Study NCT03001908 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: glenohumeral mobilization-sustained
Description: posterior glide mobilization, sustained 4 x 30 seconds
Study NCT04752306 — intervention group
Intervention type: OTHER
Intervention: Interviews
Description: Semi-structured interviews will take place between June and August 2020. Eight individual interviews with healthcare workers, ten individual interviews with residents and two individual interviews with policymakers. Interviews with the healthcare workers and policymakers will take place in a meeting room at the nursing home of employment. One interview with a policymaker will take place online. Interviews with residents will be hold in their personal room.
Study NCT01560715 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: intravitreal injection of autologous bone marrow stem cells
Description: One intravitreal injection of a 0.1-ml cell suspension containing around 10x106 bone marrow mononuclear stem cells(BMMSC). All treatments were performed by a single retinal specialist using topical proparacaine drops under sterile conditions (eyelid speculum and povidone-iodine). Autologous BMMSC were injected into the vitreous cavity using a 27 gauge needle inserted through the inferotemporal pars plana 3.0 - 3.5 mm posterior to the limbus. After the injection, central retinal artery perfusion was confirmed with indirect ophthalmoscopy. Patients were instructed to instill one drop of 0.3% ciprofloxacin into the injected eye four times daily for 1 week after the procedure.
Study NCT03491397 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Embozene MicroSpheres
Description: Embozene is a medical device made by Boston Scientific approved in the United States for the treatment of hypervascular tumors and arteriovenous malformations. It consists of thousands of microscopic spheres that are injected into the artery in the knee going to the region of pain. One of the causes of pain in the setting of knee arthritis is increased blood flow going to the specific area of pain. The goal of this procedure is to decrease the blood flow (embolize) to the specific region of the knee that is causing your pain. This is done by infusing Embozene particles into the specific blood vessel (genicular artery) supplying the area of pain in the knee.
Study NCT00913302 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cardiovascular Training
Description: cardiovascular training, 3 times/week for 30-60 minutes, over 12 weeks
Study NCT02876952 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Physical Activity Recommendations
Description: Participants will be advised to perform, without supervision, moderate to high-intensity dynamic aerobic exercise (walking, jogging, cycling or swimming) 3-5 days per week, following an adequate warm-up of 5-15 min, at moderate to high intensity (below the ischemic threshold) for a period of 20 to 40 min (not including warm-up and cool-down) followed by a cool-down period of 5-10min. Participants will receive information related to heart rate values regarding moderate and high exercise intensity domains for the self monitoring of exercise intensity.
Study NCT02876952 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: LOW VOLUME (LW) Supervised exercise
Description: Supervised exercise two nonconsecutive days per week (one day on the treadmill, and the second one on the bike) for 16 weeks. HIIT protocol on the treadmill: 5-min warm-up at a moderate-intensity, before walking 2 intervals of 4 min at high-intensity interspersed with intervals of 3 min of walking at moderate-intensity. The training session will end with a 1-4 min cool-down period at moderate-intensity. Total exercise time of 20min HIIT protocol on the bike: 10-min warm-up at moderate intensity. After that, participants will cycle for 4 repetitions (1rep = 30 s high-intensity followed by 60 s moderate-intensity) and gradually increased to 8 repetitions in LV-HIIT week by week. The training session will end with a 5-10 min cool-down period at moderate-intensity.
Study NCT01509664 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Discount intervention
Description: 50% discount on selected fruits and vegetables at participating supermarket
Study NCT02748291 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Walking
Description: The intervention group will be asked to walk a minimum 6,000 steps per day (7 days a week).~Participants will be provided with a pedometer and daily diary to record step counts.~Weekly scores will be collected via telephone contact.~Followup questionnaires will be at 6, 12 and 24 months.
Study NCT02954705 — intervention group
Intervention type: OTHER
Intervention: Non interventional study
Description: This is a non interventional study because all levies are performed during visit planned for the care of patients.
Study NCT01279837 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pharyngocise
Description: swallowing intervention by a speech language pathologist, consisting of the battery of isometric / isotonic exercises
Study NCT01279837 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Pharyngocise
Description: swallowing intervention by a speech language pathologist, consisting of the battery of isometric / isotonic exercises
Study NCT00935532 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: exenatide once weekly
Description: subcutaneous injection, 2.0mg, once a week;
Study NCT00935532 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: insulin glargine
Description: subcutaneous injection, titrated to achieve fasting serum glucose target, once a day
Study NCT02012023 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Low anterior resection
Study NCT02012023 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Low anterior resection
Study NCT02012023 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: tube ileostomy
Study NCT02748291 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Department of Health Physical Activity Guidelines
Description: 1. Adults should aim to be active daily. Over a week, activity should add up to at least 150 minutes (2½ hours) of moderate intensity activity in bouts of 10 minutes or more - one way to approach this is to do 30 minutes on at least 5 days a week.~2. Alternatively, comparable benefits can be achieved through 75 minutes of vigorous intensity activity spread across the week or combinations of moderate and vigorous intensity activity.~3. Adults should also undertake physical activity to improve muscle strength on at least two days a week.~4. All adults should minimise the amount of time spent being sedentary (sitting) for extended periods.
Study NCT02500771 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ABA therapy enhanced with V-Motive software
Description: Tutors will use the V-Motive software to enhance their delivery of Applied Behavioral Analysis therapy.
Study NCT02012023 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: loop ileostomy
Study NCT02012023 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: accept reversal operation
Study NCT02012023 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: remove the tube ileostomy
Study NCT04236687 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Holmium laser enucleation of the prostate
Description: Holmium laser will be used to enucleate the prostatic hyperplasia trough the urethra
Study NCT04236687 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Artery embolization of the prostate
Description: A catheter is placed in the prostate artery, a fluid containing thousands of tiny particles (microspheres) is injected through the catheter into these small arteries which nourish the prostate
Study NCT03520218 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Performance of R-PEM
Description: R-PEM imaging will produce high-sensitivity images with low levels of F-18 FDG and optional subsequent scans performed will display reduced levels of the injected radiotracer.
Study NCT03960853 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: pressure-controlled ventilation-volume guaranteed
Description: patients will be allocated to pressure-controlled ventilation-volume guaranteed in operation
Study NCT03960853 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: volume controlled ventilation
Description: patients will be allocated to pressure-controlled ventilation volume guaranteed in operation
Study NCT04174209 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cylinder
Description: Patients who receive the Jackson Cross Cylinder Method
Study NCT04174209 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dial
Description: Patients who receive the Astigmatic Dial Technique Method.
Study NCT04174209 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Slit
Description: Patients who receive the Stenopeic slit Method.